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Background/aims: The aim of this study was to evaluate the effects of oral tamoxifen citrate on post-
operative intra-abdominal adhesions.
Materials and methods: Forty ﬁve rats were randomly separated in to 3 groups. Group 1: Control group (15
rats), Group 2: tmx 1 group (15 rats) and Group 3: tmx 10 group (15 rats). The cecum was abraded with
a sterile gauze until subserosal hemorrhage had developed. Full- thickness 4e0 silk sutureswere also placed
in the traumatized anterior cecal wall to increase the adhesive reaction. In Group 1 (control group), adhesion
induction was performed and no treatment was given. In Group 2 (tmx 1 group), after adhesion induction,
1mg/kg/day tamoxifen citratewas givenbyorogastric gavage. InGroup3 (tmx10 group), adhesion induction
was performed and 10 mg/kg/day tamoxifen citrate was given by orogastric gavage. Rats were sacriﬁced on
postoperative day 30. At the time of second surgery, after the abdominal fascia had been opened blood
samples were collected to evaluate serum TGFb-1 levels and following the macroscopic adhesion scoring,
tissue specimens of the bowel and adhesions were subjected to histopathological investigation.
Results: In group 1 and group 2 we detected higher scores for the macroscopic classiﬁcation (2.25  1.13 vs.
1.53  0.77) and histopathological scores (2.72  0.64 vs. 2.53  0.87) for ﬁbrosis and serum TGFb-1 levels
(42000 2935vs. 32988 10804). In group3wehavedetecteddecreased scores formacroscopic classiﬁcation
(0.91  0.51) and histopathological scores (1.58  0.90) for ﬁbrosis and serum TGFb-1 levels (22847  4976).
Therewere no signiﬁcant differences between group 1 and group 2 according to themacroscopic classiﬁcation
and pathological scores forﬁbrosis. Therewere statistically signiﬁcant difference between tamoxifen 10mg/kg
group and the other groups according tomacroscopic classiﬁcation ( P: G1-3: 0.004; G2-3: 0.046), pathological
scores for ﬁbrosis (P: G1-3: 0.004; G2-3: 0.011) and serum TGFb-1 levels (P: G1-3:<0.001).
Conclusions: In conclusion tamoxifen citrate seems to be useful for preventing postoperative intra-
abdominal adhesions. Its effects are in a dose and time dependent manner. Further studies must be
carried out to use tamoxifen for preventing intra-abdominal postoperative adhesions in clinical practice.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Intraabdominal adhesionsmay be postoperative, inﬂammatory or
rarely congenital. Mechanical injury, foreign bodies, ischemia and
infection in abdominal operations can increase the severity of adhe-
sions. Postoperative intraabdominal adhesions are the major causes
of morbidity after laparotomy.1e3 Postoperative intraabdominal
adhesions are ﬁbrotic bands that can be form between an organ and
peritoneum, omentum and intestine or intestine and intestine.up, General Surgery, Ornek-
530 414 75 30.
s¸).
ciates Ltd. Published by Elsevier LtIntra-abdominal adhesions causes complications such as post-
operative pain, bowel obstruction and infertility. Fibroblasts isolated
from normal peritoneum and from adhesions have been showed to
have signiﬁcant molecular differences.4 These differences include
phenotypic alterations in adhesion ﬁbroblasts such as a reduction in
both the ratio of tissue plasminogen activator/plasminogen acti-
vator inhibitor-1 and in the rate of apoptosis under hypoxic condi-
tions, and greater ability to produce the inﬂammatory cytokine
transforming growth factor- b (TGF b) and extracellular matrix
molecules, than normal peritoneal ﬁbroblasts.5,6
TGFb-1 is a growth factor with a wide variety of tissue-speciﬁc
effects. TGFb-1 stimulates ﬁbroblasts to product many proteins,
including collagen, ﬁbronectin, and integrins. It also decreases thed. All rights reserved.
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lular matrix, such as collagenase and heparinase.7 TGF b is an
extremely potent chemoattractant for macrophages, mononuclear
leukocytes and ﬁbroblasts and it acts as a potent stimulant for
collagen and ﬁbronectin synthesis and inhibits epithelial cell
growth. Of the isoforms of TGF b, TGFb-1 and TGF b-2 have been
associated with ﬁbrogenic conditions, whereas TGF b-3 tends to
decrease ﬁbrosis and scarring.
TGFb-1 has been showed to stimulate ﬁbroblast proliferation
and the production of extra cellular matrix (ECM) components
in vitro, making it a prime candidate as a causative factor.8,9
Tamoxifen citrate is a synthetic nonsteroidal antiestrogen, used
in the treatment of breast cancer. It has been shown to inhibit
keloid ﬁbroblast proliferation and decrease collagen production.
Tamoxifen decreases the total (all 3 isomers) TGF b produced by
keloid ﬁbroblast in cell culture in a dose dependent manner.10
2. Materials and methods
Forty ﬁve Wistar-Albino female rats, weighing 250  25 g, were housed indi-
vidually inwire cages under constant temperature (212 C) with a 12 h lightedark
cycle. The animals were allowed free access to water and standard rat chow. Twelve
hours before anesthesia, animals were deprived of food, but had free access to water
2 h before anesthesia. No enteral or parenteral antibiotics were administered during
the study. The procedures in this experimental study were performed in accordance
with the National Guidelines for the Care and Use of Laboratory Animals and
approved by the Animal Ethics Committee of Ankara Research and Training Hospital.
Rats were randomly divided into three groups of 15 animals each. All animals
were anesthetized by intramuscular injection of 30 mg/kg ketamine hydrochloride
(Ketalar, Parke-Davis, Istanbul) and 5 mg/kg xylazine (Rompun, Bayer, Istanbul).
Liposomal povidone-iodine hydrogel (Repithel) was purchased from Mundi-
pharma GmbH (Limburg, Germany). After the rats were anesthetized, the abdomen
was shaved and prepared with povidone-iodine. Under sterile conditions and with
powder free gloves, 3 cm long midline incision was made up, and the anterior cecal
wall was abraded with 20 strokes of a toothbrush. Also full thickness 4e0 silk
sutures were placed in the traumatized anterior cecal wall to increase the adhesion
reaction. The abdominal incision was closed in two layers with simple, continuous
sutures of silk 3/0. The methods were described by Oncel M. et al.13
In Group 1 (control group), adhesion inductionwas performed and no treatment
was given. In Group 2 (tmx 1 group), after adhesion induction, 1 mg/kg/day
tamoxifen citrate (Sigma Chemical Co, St Louis, USA) was given by orogastric gavage.
In Group 3 (tmx 10 group), after adhesion induction, 10 mg/kg/day tamoxifen citrate
was given by orogastric gavage. Animals were allowed access to food and water after
the operation. All operations were performed by the same surgeon. Rats were
sacriﬁced with high dose ethered on postoperative day 30. Blood samples were
collected at the time of second surgery, after the abdominal fascia has been opened
and immediately centrifuged at 30 000 rpm for 5 min at 4 C. The serum was
aspirated and stored at 80 C until analyzed. Adhesions were scored using the
macroscopic classiﬁcation described by Zühlke et al.14
1 Filmy and easy to separate by blunt dissection
2 Blunt dissection possible, partly sharp dissection necessary, beginning
vascularization
3 Lysis possible by sharp dissection only, clear vascularization
4 Lysis possible by sharp dissection only, organs strongly attached with severe
adhesions, damage of organs hardly preventable.
The histopathological analyses were carried out in the Pathology Department of
Kecioren Research and Training Hospital. Histopathological examination wasTable 1
The mean adhesion scores for macroscopic classiﬁcation, histopathological examination
P value (Kruskal
Wallis analyses)
Group 1 (n:12)
mean score  s.d
G
m
Macroscopic classiﬁcation 0.004 2.25  1.13
TGFb-1 <0.001 42000  2935 3
Histopathology 0.003 2.72  0.64performed by using light microscopy. The samples obtained from the abraded cecal
tissue and the adjacent peritoneal tissue was ﬁxed in 10% neutral buffered formalin
solution for 2 days. Tissues were washed in running water, and were dehydrated
with increasing concentrations of ethanol (50%, 75%, 96% and 100%).
After dehydration, specimens were placed into xylene to obtain transparency
and embedded in parafﬁn. Embedded tissues were cut into 5 mm-thick sections and
were stained with hematoxylin/eosin and trichrome. Histopathologic examinations
were performed by a pathologist blinded to the study groups. Histological classiﬁ-
cation were carried out according to the criteria mentioned by Yılmaz et al.15
0 No ﬁbrosis
1 Thin bunches of a cellular ﬁbrosis
2 Wide areas of ﬁbrosis with reduced vascularization
3 Areas of ﬁbrosis formed by thick bunch of collagen
Serum TGFb-1 protein levels were assessed by enzyme-linked immunosorbent
assay (ELIZA) using a kit speciﬁc for TGFb-1. Kit was purchased from Invitrogen
Corporation. (Camarillo, CA, USA). Total protein concentrations were determined by
spectrophotometry, and specimens were subsequently brought to equal concen-
trations by dilution with the appropriate amount of mild lysis buffer.
All specimens were acidiﬁed for 1 h to facilitate quantiﬁcation of total TGFb-1
level, followed by neutralization immediately prior to conducting the ELISA.
Samples were then analyzed by ELISA with serial dilutions of known quantities of
recombinant TGFb-1, used as a positive control and standard to quantify the absolute
TGFb-1 protein content of each sample. All specimens were analyzed in duplicate,
and the assay was repeated at least 3 times. All TGFb-1 results are given as pico-
grams per microliter.
Data analysis was performed using the SPSS Inc. Chicago IL15.0 package
program. KruskaleWallis test was used to test for differences in three groups. A
Mann Whitney U statistic analyses was used as a non-parametric test to determine
differences between groups. A P value < 0.05 was considered signiﬁcant, and a P
value < 0.001 was considered highly signiﬁcant.
3. Results
A total of 45 rats sacriﬁced on postoperative 30th days. Group 1:
Control group (15 rats), Group 2: tmx 1 group (15 rats) and Group 3:
tmx 10 group (15 rats).
The mean adhesion scores for macroscopic classiﬁcation,
histopathological examination and the mean serum TGFb-1 levels
are summarized in Table 1.
3.1. Intra-abdominal adhesion scores
In group 1 and group 2 we detected higher scores for the
macroscopic classiﬁcation (2.25  1.13 vs. 1.53  0.77). In group 3
we have detected decreased scores for the for macroscopic classi-
ﬁcation (0.91  0.51). There were no signiﬁcant difference between
group 1 and group 2 according to the macroscopic classiﬁcation.
There were statistically signiﬁcant difference between tamoxifen
10 mg/kg group and the other groups according to the macroscopic
classiﬁcation (P: G1-3: 0.004; G2-3: 0.046).
3.2. Histopathological scores
In group 1 and group 2 we detected higher scores for histo-
pathological scores (mean scores: 2.72  0.64 vs. 2.53  0.87) forand the mean serum TGFb-1 levels.
roup 2 (n:13)
ean score  s.d
Group 3 (n:12)
mean score  s.d
P value (Mann Whitney U test)
1.53  0.77 0.91  0.51 G1-2: 0.087
G1-3: 0.004
G2-3: 0.046
2988  10804 22847  4976 G1-2: 0.040
G1-3: <0.001
G2-3: 0.052
2.53  0.87 1.58  0.90 G1-2: 0.649
G1-3: 0.004
G2-3: 0.011
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logical scores (mean score: 1.58  0.90) for ﬁbrosis. There were no
signiﬁcant difference between group 1 and group 2 according to
histopathological scores for ﬁbrosis. There were statistically
signiﬁcant difference between tamoxifen 10 mg/kg group and the
other groups according to histopathological scores for ﬁbrosis (P:
G1-3: 0.004; G2-3: 0.011).Fig. 2. Cecal abrasion.3.3. Serum TGFb-1 levels
For serum TGFb-1 levels in group 1 and group 2 we detected
higher scores (mean scores: 42000  2935 vs. 32988  10804). But
in group 3 we have detected the lowest scores for serum TGFb-1
levels (mean score: 22847  4976). According to serum TGFb-1
levels there was no signiﬁcant difference between group 2 and
group 3, but there were statistically signiﬁcant difference between
group1 and group 3 and between group 1 and group 2 (P: G1-3:
<0.001 vs. G1-2: 0.04).
The images of adhesions and abrasion of cecum are shown in
Figs. 1e3.
The histopathological images of the pathological scores are
shown in Figs. 4e7.4. Discussion
Despite improvements in surgical techniques and instruments,
postoperative intra-abdominal adhesions are still a challenging
problem and major cause of morbidity and mortality.
Postoperative adhesions can form after trauma to the peritoneal
cavity, inﬂammatory conditions, intraperitoneal infection,
congenital, tissue ischemia and intraabdominal presence of foreign
material such as blood or bile. Peritoneal adhesions are deﬁned as
ﬁbrous bands of tissue that join together organs that are normally
separated.
Peritoneal mesothelial cells provide a natural protective barrier
thatprevents the organs fromadhering to adjacentopposing surfaces.
In normal peritoneum, ﬁbrinolytic activators in the mesothelium
convert plasminogen to plasminwhich lyses ﬁbrin.1 Usually the rates
of ﬁbrin deposition and ﬁbrinolysis are equal. However, the factors
that cause intraperitoneal adhesion impair the ﬁbrinolytic activators
and lead to excess ﬁbrin deposition.1,11e14 If cellular or tissue injury is
relatively extensive, leading to excess migration and proliferation of
variouswound cells, i.e.ﬁbroblasts, this response initiates a cascade ofFig. 1. Grade 2 and 3 adhesions between abdominal wall, cecum and small intestine.events that often results in the development of peritoneal adhesions.
These adhesions are known to be the major cause of bowel obstruc-
tion, pain, infertility and hospital readmission.15e17
Postoperative intraabdominal adhesions at the peritoneum
most commonly form within seven to ten days and become
persistent after fourteen days.18 Therefore this stage is critical in
preventing adhesion formation, and efforts to combat adhesion
formation concentrate mostly on this phase.
Peritoneum has an intrinsic ﬁbrinolytic activity that breaks the
peritoneal adhesions. Peritoneal injuries with ischemia interfore
this ﬁbrinolytic activity and cause adhesions. The ﬁbrotic response
also involves increased production of cytokines and growth factors,
including TGF b1 and connective tissue growth factor (CTFG).
TGF b1 has been shown to stimulate ﬁbroblast proliferation and
the production of ECM, making it a prime candidate as a causative
factor.8,9 Experimental data from peritoneal adhesions in human
and animal models of surgically induced adhesions suggest that the
local over-expression of TGF b is a key to development of adhe-
sions.19e24 TGF-b1 induces many of the processes involved in
ﬁbrosis, including ﬁbroblast to myoﬁbroblast transdifferentiation,
ECM deposition, although without inducing inﬂammation. Chegini
et al. demonstrated that adhesions express a higher concentration
of TGF-b1, with large bowel and omentum expressing the lowestFig. 3. Grade 2 adhesion between cecum and abdominal wall.
Fig. 4. Grade 1 adhesion between ceacum and abdominal wall. Poor blood vessels and
inﬂamatuar cells and few collagen ﬁbers.
Fig. 6. Grade 3 adhesion.
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able than TGF-b1 with uterine serosa expressing the highest
concentration.25 Hobson et al. conﬁrmed that human peritoneal
adhesions contain high amounts of TGF-b1 compared with normal
tissue and the increased TGF-b1 expression in scar tissue persists
for several years after the initial injury.26
Williams et al. were designed a study to measure the effect of
exogenous TGF b on postoperative peritoneal wound healing and
they were demonstrated that TGF b increases the severity of
adhesion formation after surgical injury, but has no effect on
uninjured peritoneum.19
Tamoxifen citrate is a synthetic nonsteroidal antiestrogen agent
mainly used in the treatment of breast cancer. It may also be
effective in the treatment of abnormal proliferative healing disor-
ders. In vitro studies have shown that tamoxifen inhibits the
proliferation of keloid ﬁbroblasts, decreases the rate of collagen
synthesis, decreases the production of TGF b and decreases the
ability to contract ﬁbroblast-populated collagen lattices.10,27e29
Mc Namara et al. showed that there were not signiﬁcant differ-
ence in adhesion scores between placebo treated and tamoxifenFig. 5. Grade 2 adhesion. Immature connective tissue, blood vessels, inﬂamatuar cells,
and thin collagen ﬁbers.treated rats on postoperative 3, 5 and 7 days,30 although Nilsson
et al. showed that long term tamoxifen treatment decreased the
secreted levels of TGF b1 whereas estradiol increased these
levels.31e33 They found that 24 h of tamoxifen treatment gave
a signiﬁcant increase in TGF b1 protein levels in conditioned media.
In contrast to the short term treatment, tamoxifen treatment for
seven days signiﬁcantly decreased TGF b1 protein levels. In vivo
experiments showed that tamoxifen treatment was signiﬁcantly
decreased angiogenesis and TGF b1 protein levels in solid breast
cancer.
The adhesion formation is related to the time of the second
surgery because postoperative adhesions at the peritoneum most
commonly from within 7e10 days and become persistant after 14
days.18 The time of second surgery at Mc Namara study seems to be
early to evaluate postoperative adhesion. So that we sacriﬁced rats
on postoperative 30 days.
In the present study, we utilized a ratmodel to compare the effect
of tamoxifen 1 mg/kg and 10 mg/kg on postoperative adhesions. We
found that treatment with tamoxifen 10mg/kg signiﬁcantly reduced
postoperative adhesion formation.We founda statistically signiﬁcant
difference between control group and tamoxifen 10 mg/kg group.Fig. 7. Grade 3 adhesion. Thick collagen ﬁbers and mature connective tissue.
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10mg/kg and 1mg/kg groups. The differences between control group
and tamoxifen 1 mg/kg group were not statistically signiﬁcant.
TGFb-1 levelswere signiﬁcantly reducedwith tamoxifen10mg/kg
treatment. There were statistically signiﬁcant difference between
tamoxifen 10 mg/kg group and control group.
The pathological scores for ﬁbrosis were signiﬁcantly different
between tamoxifen 10 mg/kg group and the other groups.
We detected connective tissue maturation and being wide-
spread of collagenation for ﬁbrosis scoring. In Tamoxifen 10 mg/kg
treatment group the production of collagen connective tissue was
reduced while it was signiﬁcantly induced in control group and
tamoxifen 1 mg/kg group.
In tamoxifen 1 mg/kg group we also found that connective
tissue were more extensive and spread about striated muscle and
smooth muscle of bowel. It was also rich from inﬂammatory cells.
Tamoxifen 1 mg/kg was not reduced enough TGFb-1 levels. So that
more extensive connective tissue and rich inﬂammatory cells were
found.
We have detected the antiﬁbrotic effects of tamoxifen citrate in
supra-therapeutic doses, yet we don’t know the possible side
effects of supra-therapeutic doses in human being especially in
man. We used supra-therapeutic doses of tamoxifen citrate to see
the antiﬁbrotic effects in short term therapy, so a long term therapy
should be scheduled with lesser doses of tamoxifen citrate to see
the same effects. Further studies are needed to see the side effects
of supra therapeutic doses in human being or to evaluate the choice
of long term therapy with therapeutic doses. To our knowledge
there are not any other inhibitors of TGFb-1 used in vivo or in vitro
studies as tamoxifen citrate.
5. Conclusion
In conclusion, the antiﬁbrotic effects of tamoxifen are related
with the reduced TGFb-1 levels, so it reduces postoperative adhe-
sions in a dose and time dependent manner. Our study indicates
that tamoxifen may be used as a preventive agent for postoperative
intra-abdominal adhesions. Further experimental and clinical
studies are needed to use tamoxifen in clinical practice as
a preventive agent for postoperative intra-abdominal adhesions.
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